Introduction
Synthesis of the intracellular second messenger cAMP by adenylyl cyclase stimulates activation of cAMP-binding proteins such as cyclic nucleotidegated channels 1 and Epac guanine nucleotide exchange factors, 2 with the principal intracellular target being protein kinase A (PKA). 3 Although cAMP is diffusible, rises in cAMP concentration are restricted to microdomains of the cell. 4 A-kinase anchoring proteins (AKAPs) organise signalling within cAMP microdomains by anchoring multiple signalling proteins, 5 which in addition to PKA and other signalling proteins include the enzymes responsible for cAMP synthesis 6 and breakdown. 7 Recent investigations of AKAPs challenge the view of scaffold proteins as inert platforms that merely colocalise discrete subsets of proteins. Despite considerable structural and functional diversity, all AKAPs share three common properties: an amphipathic helix to anchor the PKA holoenzyme through interaction with the N-terminal docking/dimerisation (D/D) domain of its regulatory (R) subunits [8] [9] [10] ; targeting elements to particular subcellular locations; and the ability to bind other signalling proteins. 5 Subcellular location of AKAPs is often dynamic; for example, AKAP79 is released from the cell membrane following rises in calcium concentration and activation of calmodulin. 11 The ability of AKAPs to bind multiple proteins provides a mechanism to integrate different second messenger signals; for example, AKAP-Lbc inputs signals from both protein kinase C and PKA to activate protein kinase D. 12 AKAPs may also modulate the properties of bound proteins; for example, 3-phosphoinositide protein kinase 1 is activated upon engaging mAKAP 13 and Yotiao can directly increase the current passing through the heart potassium channel IK 5 . 14 Consistent with their role in organising signalling complexes, AKAPs are involved in important biological processes; for example, AKAP79 targets PKA and protein phosphatase 2B for respective phosphorylation and dephosphorylation of a glutamate receptor critical in hippocampal synaptic plasticity, 15, 16 and mAKAP anchors an array of signalling enzymes 17 for regulation of various aspects of heart function including calcium release from the sarcoplasmic reticulum. 18 Many AKAPs are expressed as alternatively spliced isoforms. The AKAP15/18 gene encodes four splice variants ( Supplementary Fig. S1 ) that range in size from 15 to 37 kDa. These anchoring proteins utilise distinct targeting motifs to determine specific subcellular locations. [19] [20] [21] Membrane targeting of the α and β variants is mediated by lipid modification of sites at the extreme amino terminus, 22, 23 whereas the larger δ variant is predominantly cytoplasmic. 24 Under certain circumstances, the AKAP18γ variant is believed to reside in the nucleus. 25 Nonetheless, all four variants contain an R subunit-binding helix, which binds both PKA regulatory subunit isoforms, [19] [20] [21] and a putative leucine zipper motif that anchors at least the α isoform to L-type calcium channels. 26 AKAP18α plays a role in the brain, where it directs PKA toward neuronal sodium channels, 27 allowing their dopaminergic modulation. 28 More recently, the δ isoform has been shown to anchor PKA for both phosphorylation of aquaporin-2 at Ser256 following vasopressin stimulation in the kidney 29 and phosphorylation of phospholamaban in the heart. 30 AKAP18δ has also been reported to bind to PDE4D isoforms through elements within its central region. 31 Knowledge of the three-dimensional structures of proteins provides crucial insights into protein function unavailable from other observations. However, structural information for AKAPs has to date been limited to studies of the AKAP-PKA interaction. [8] [9] [10] For a variety of reasons, AKAPs are challenging targets for crystallographic investigation. AKAPs are often large proteins that can be difficult to express in bacteria. Generally, AKAP sequences are thought to be of low complexity, containing few discrete globular folded domains. Additional problems arise because most AKAPs simultaneously interact with multiple binding partners, so heterologous expression in their absence may destabilise protein structure and increase protein degradation.
To define features in AKAPs that might be amenable to structural analysis, we analysed mammalian AKAPs by a bioinformatics approach to identify putative globular domains. Here, we present the identification and structure determination of a central domain (∼ 200 residues) common to AKAP18γ/δ (termed AKAP18 CD ). Our results, the first crystal structure of an AKAP domain, reveal a structural resemblance to the 2H phosphoesterase family, proteins that harbour a pair of conserved Hisx-Thr motifs. Members of this family include RNA ligases and cyclic nucleotide phosphoesterases.
Characterisation of the domain revealed that AKAP18 CD specifically interacts with 5′AMP and cytosine monophosphate (CMP), but lacks a range of phosphoesterase activities. These data suggest that either AKAP18δ acts as a phosphoesterase for an unidentified substrate or functions as an AMP sensor, thereby coupling intracellular AMP levels with PKA-mediated phosphorylation processes.
Results

AKAP18δ incorporates a 2H phosphoesterase domain
The longest splice variant of each known mammalian AKAP (20 proteins) was analysed using the secondary structure prediction program JPRED 32 and the protein tertiary structure recognition program PHYRE 33 ( Table 1) . Regions of discrete nonrepetitive secondary structure were predicted by JPRED, for example, a C-terminal region in AKAP95 (approximately residues 360-692) and throughout the short AKAP, AKAP28. Protein fold recognition analysis indicated regions of potential architectural similarity to proteins of known structure. Domains detected in some AKAPs had previously been characterised (e.g., the RhoGEF domain of AKAP-Lbc), whereas in other AKAPs, novel domain definitions using PHYRE were strongly supported by high (N 40%) sequence identity with the identified structural homologue (e.g., the Sec7 domain in BIG2). Structural analysis of these regions would be less likely to yield much in the way of new functional information. Of more interest was the detection of structural homology within AKAPs to proteins of known fold, not clearly evident from sequence analysis alone. These included the long AKAP18 isoforms γ and δ, identified as incorporating a central domain likely to resemble members of the 2H phosphoesterase family, despite the absence of significant sequence similarity (17%) ( Table 1) .
To address the structural and functional properties of AKAP18δ, three constructs for bacterial expression of rat AKAP18δ were designed corresponding to full-length protein, an N-terminal truncation (residues 76-357) and the limited central domain (76-292), termed AKAP18 CD (Supplementary Fig. S1 ). The central domain was purified by glutathione affinity and gel filtration chromatography, whereas the longer proteins eluted in the void volume on gel filtration and were not investigated further. AKAP18
CD was crystallised by hangingdrop vapour diffusion, and the structure was determined at 1.8 Å resolution by single isomorphous replacement with anomalous scattering (SIRAS). Data collection, phasing and refinement statistics are listed in Table 2. AKAP18 CD adopts a globular α-β-type architecture consisting of four α-helices and eight β-sheets, with approximate dimensions of 50 Å × 40 Å × 30 Å. The domain is bilobal with two four-stranded anti-parallel β-sheets at its core related by a pseudo 2-fold rotational symmetry (Fig. 1a) . A deep, waterlined groove lies between the two lobes and penetrates approximately 15 Å into one face of the protein. The strands β2 and β5 run antiparallel to each other at the base of this groove (Fig. 1a) , and each harbours a His-x-Thr motif that defines the 2H phosphoesterase family 34 and is conserved in AKAP18γ/δ across species (Fig. 1b) .
The side chains of residues Arg219 and Thr220 (arginine-containing 'R' loop, connecting α3 to β5, Fig. 1a) are not visible in the electron density map and the main-chain atoms of these residues are relatively mobile (bBN main chain of 40.4 Å 2 for residues 219 and 220 compared to overall bBN main chain of 30.0 Å 2 ). This region lies at one entrance to the groove, adjacent to another flexible loop region (residues 179-182, connecting β3 and β4) that also possesses relatively high B-factors (bBN main chain of 37.8 Å 2 ).
AKAP18δ binds 5′AMP and 5′CMP specifically
Because 2H phosphoesterases catalyse reactions involving nucleotides, we tested the nucleotidebinding capability of AKAP18δ by co-crystallising AKAP18 CD in the presence of a variety of nucleotides. In each instance, a complete data set was collected at higher than 2.5 Å resolution, and the presence of nucleotide was detected by determining the structure by molecular replacement. Significantly, electron density characteristic of nucleotide was visible in F o − F c difference maps when AKAP18 CD was co-crystallised in the presence of The longest isoform of each mammalian AKAP was systematically investigated for regions of discrete nonrepetitive secondary structure using the secondary structure prediction program JPRED and for regions of potential structural similarity to proteins of known structure by the fold recognition program PHYRE. C1, cysteine-rich phorbol-binding domain; DH, Dbl homology; KH, K homology; PH, Pleckstrin homology; RGS, regulator of G-protein signaling. a Gene nomenclature committee names are in parentheses. b Regions of greater than 50 amino acids with no predicted secondary structure are listed. c Alignments with estimated precision of 10% or below were discounted-for AKAPs N1200 residues, the sequence was broken into blocks of 1200 amino acids with 400-residue overlaps.
either 5′AMP or 5′CMP. However, there was no electron density suggestive of nucleotide after co-crystallisation with a range of other nucleotides, including 3′AMP, guanosine 5′-monophosphate (5′GMP) and thymidine 5′-monophosphate (5′TMP), as listed in Fig. 2a . Co-crystallisation with decreasing concentrations of 5′AMP indicated that the ligand binds with a dissociation constant (K d ) in the midmicromolar range (Fig. 2a) .
The affinity constant for 5′AMP was more accurately quantified by equilibrium fluorescence binding using the AMP derivative 2′-(or 3′)-O-(Nmethylanthraniloyl) adenosine 5′-monophosphate (MANT-AMP). MANT fluoresces at 448 nm upon excitation near 335 nm, which allows protein binding to be detected by FRET upon excitation at 290 nm. A plot of the difference in fluorescence in the presence and absence of AKAP18 CD over a range of MANT-AMP concentrations reveals the fraction of AKAP18 CD that is bound to MANT-AMP at a given concentration. As the concentration of AKAP18 CD (25 μM) is low, the K d for MANT-AMP can be approximated by fitting the data to a hyperbolic function. Iterative rounds of least square fitting modelled the data shown in To understand the molecular basis for preferential binding to 5′AMP/CMP rather than 5′GMP/TMP, structures of AKAP18 CD in complex with 5′AMP and 5′CMP were refined at 1.5 and 2.25 Å resolution, respectively. Data collection and refinement statistics for these complex crystal structures are listed in Table 2 . In both complexes, nucleotide binds within the deep groove of the AKAP18δ central domain with the phosphate moiety coordinated by the two His-x-Thr motifs, and the base moiety contacted by residues from the β3/β4 and R loops (Fig. 3) .
Coordination of the identical ribose and phosphate moieties of 5′AMP and 5′CMP by AKAP18 CD is very similar. At the base of the groove, the two His-x-Thr motifs dominate interactions to the nucleotide phosphate group via a network of direct and water-mediated hydrogen bonds (Fig. 4a) . The two threonine residues (134 and 226) of the His-xThr motifs donate direct hydrogen bonds to phosphate oxygen atoms, whereas His224 of the second His-x-Thr motif donates a hydrogen bond to the ester oxygen. Water-mediated hydrogen bonds to phosphate oxygen atoms are provided by the sidechain amine of Lys229 and by main-chain amide (Thr134) and carbonyl (His132) groups. The only interaction to the ribose moiety is a van der Waals contact with Val183 (Fig. 4a ). This residue, like the majority of the residues lining the groove, is invariant in AKAP18 across all species (Fig. 1b) .
The ribose hydroxyl groups of 5′AMP are solvent accessible (Fig. 3b) .
The base moieties of both 5′AMP and 5′CMP are sandwiched between the side chains of Phe179 and Arg219, at one entrance to the groove (Fig. 4b and c) . Arg219 forms a cation-π interaction with the adenine moiety of 5′AMP (Figs. 3b and 4b ) and with the cytidine moiety of 5′CMP (Fig. 4c) , an interaction known to stabilise protein-DNA complexes, while Phe179 forms a π-stacking interaction on the opposite side of the base. The binding of nucleotide stabilises and immobilises the loops harbouring Phe179 (β3/β4 loop) and Arg219 (R loop), with concomitant ordering of the side chains of Arg219 and Thr220. Two water-mediated proteinbase hydrogen bonds are also visible in the 5′AMP complex structure: adenine position N6 to the mainchain carbonyl of Thr220 and position N7 to the main-chain amide of Lys222 (Fig. 4b) . Residues involved in the coordination of phosphate and adenosine moieties of 5′AMP/CMP are respectively labelled with black and red triangles in the sequence alignment (Fig. 1b) . The coordination of 5′AMP and 5′CMP suggests that a contact between the backbone carbonyl of Thr220 and the group attached to C6 (purine, Fig.  4b ) or C4 (pyrimidine, Fig. 4c ) of the base provides base specificity for AKAP18δ. In the 5′AMP complex, the amine in this position is 3.5 Å from the carbonyl of Thr220 (Fig. 4b) ; the equivalent distance is 4.1 Å for the 5′CMP complex (Fig. 4c) . Both are close enough that substitution of carbonyl for amine, as in guanine and thymidine, would cause a repulsive interaction with the carbonyl of Thr220, accounting for the specificity of AKAP18δ for 5′AMP and 5′CMP.
We performed further co-crystallisations to explore nucleotide specificity. ATP, ADP and NADP did not associate with AKAP18
CD . These results may be rationalised from the coordination observed for the mononucleotides 5′AMP and 5′CMP; there is no space for the additional phosphate group of a dinucleotide. The cyclic nucleotides 3′-5′ cAMP, its nonhydrolysable analogue Rp-cAMPS, and the cyclic nucleotides cyclic 2′-3′ cytosine monophosphate (2′-3′ cCMP) and cyclic 2′-3′ nicotinamide diphosphate (2′-3′ cNADP) also failed to bind when present at 5 mM in the crystallisation solution (Fig. 2a) . Any of these cyclic nucleotides would be unable to satisfy the precise network of hydrogen bonds coordinating the phosphate and ribose moieties in the 5′AMP complex (Fig. 4a) . The nucleotidebinding properties that we observed in the crystal are likely to be a true reflection of the binding capabilities of AKAP18δ, as the highly conserved groove region is not influenced by crystal lattice contacts. 
AKAP18
CD resembles bacterial 2′-5′ RNA ligases
The DALI † server 35 was used to search for structural homologues of AKAP18 CD (Supplementary  Table S1 ) (Fig. 5) . As expected, the domain aligned with 2H phosphoesterase proteins. The closest superpositions were to bacterial 2′-5′ RNA ligases from Pyrococcus horikoshii 36 and Thermus thermophilus.
37
The domain also superposed well with Arabidopsis thaliana 1′-2′-cyclic nucleotide 2′-phosphodiesterase, 39 although less well to goldfish 40 and human 41 brain 2′-3′-cyclic nucleotide 3′-phosphodiesterases. The existence of the 2H phosphoesterase protein superfamily has been recognised for some time, 34 but the functions of the various superfamily members remain poorly understood. The 2′-5′ RNA ligases catalyse the ligation of half-tRNA molecules with 2′-3′-cyclic phosphate and 5′-hydroxyl termini (Fig. 6a) . A. thaliana 1′-2′-cyclic nucleotide 2′-phosphodiesterase hydrolyses ADP-ribose 1″,2″-cyclic phosphate (ApprNr), a product of the tRNA splicing reaction (Hoffman et al., 2000) (Fig. 6b) . Brain 2′-3′-cyclic nucleotide 3′-phosphodiesterase remains an enigma-its physiological substrate is still unknown despite considerable investigation of its biological roles. Although the protein is capable of hydrolysing the cyclic phosphodiester of the unphysiological molecule cyclic 2′-3′ NADP, its role as a phosphodiesterase is controversial. The 2H phosphoesterase superfamily comprises 10 subfamilies, with four major clades. 42 AKAP18δ is assigned to the eukaryotic LigT subfamily comprising eight mem- † http://www.ebi.ac.uk/dali/ bers. One of these, the human protein activating cointegrator 1, which assembles into a four-subunit transcription co-activator complex, 43 bears little similarity to AKAP18δ except for the central His-xThr motifs. Interestingly, some superfamily members are coupled to UBA and SH3 domains, suggesting a possible function in signal transduction.
Structural alignment of the AKAP18δ binding groove with homologous 2H phosphoesterases (Fig. 5) indicates that numerous highly conserved residues are shared between AKAP18δ (Fig. 5a ) and 2′-5′ ligases from P. horikoshii (Fig. 5b ) 36 and T. thermophilus (Fig. 5c) . 37 Equivalent residues for both His-x-Thr motifs, Phe179, Val183 and Tyr280 are positioned within the 2′-5′ RNA ligase-binding grooves (Fig. 5b and c) . Lys229 in AKAP18δ is replaced by arginine in the RNA ligases, a conservative substitution, and Val137 is replaced by phenylalanine ( Fig. 5b and c) . Arg219 in the AKAP18δ R loop is replaced by either glycine (Fig. 5b) or lysine (Fig. 5c ) in the 2′-5′ RNA ligases. Apart from the His-x-Thr motifs, AKAP18 CD is less similar to A. thaliana 1′-2′-cyclic nucleotide 2′-phosphodiesterase. 39, 38 Specifically, there are no counterparts to Arg219 and Phe179 (Fig. 5d) . Finally, the AKAP18δ-binding groove bears little similarity to 2′-3′-cyclic nucleotide 3′-phosphodiesterases. 40, 41 AKAP18δ lacks a range of cyclic nucleotide -phosphoesterase activities All known 2H phosphoesterase catalytic reactions involve nucleophilic attack of a cyclic phosphate, although the product of the reaction varies depending on the attacking group and linkage positions of the substrate phosphodiester. A putative mechanism for the T. thermophilus 2′-5′ RNA ligase has been proposed (Fig. 6a) . 37 His130 functions to activate the 5′ hydroxyl of a tRNA half-molecule for nucleophilic attack onto the cyclic phosphate of a second tRNA half-molecule. Thr41, Thr132 and Arg135 are proposed to anchor the cyclic phosphate, while His39 protonates the 2ʺ-oxygen of the cyclic phosphate and promotes P-O bond cleavage. In this instance, the product of the reaction is the linkage of two RNA half-molecules via a 2′-5′ phosphodiester bond. 37 Since residues lining the AKAP18δ groove (Fig. 5a ) are conserved with 2′-5′ RNA ligase (Fig.  5c) , the AKAP18δ-5′AMP complex crystal structure serves as a model to elaborate the proposed catalytic model. 37 It is likely that Phe80 and Val88 of the ligase (equivalent to Phe179 and Val183 of AKAP18δ), respectively, coordinate the base and ribose moieties of the 3′ tRNA half-molecule (Fig.  6a) . Furthermore, Arg135 (Lys229 of AKAP18δ) is suitably positioned to allow for stabilisation of a pentaphosphate transition state (Fig. 6a) . This geometry suggests that Phe44 (Fig. 5c) , on the other side of the binding groove, is likely to be involved in coordinating the 5′ tRNA half-molecule.
In AKAP18δ, the presence of both His-x-Thr motifs could enable activation of a water or 5′-hydroxyl group for nucleophilic attack and protonation of a leaving oxygen group to complete the catalytic reaction. Interestingly, His132, the putative acid (Fig. 6a) , is conserved and not involved in contacts with 5′AMP (Fig. 4a) . Potentially important distinctions between the AKAP18δ and 2′-5′ RNA ligase binding grooves are the positions of phenylalanine and lysine/glycine (Figs. 5c and 6a ) in the ligases at the equivalent positions to Val137 and Arg219, respectively, of AKAP18δ (Figs. 5a and 6c) . Residues of AKAP18δ remote from the binding groove share less than 15% identity with the 2′-5′ RNA ligases. The catalytic mechanism of A. thaliana 1′-2′-cyclic nucleotide 2′-phosphodiesterase 39,38 is similar, although in this instance water is activated for nucleophilic attack and the cyclic phosphate forms ester bonds at 1′-2′ (Fig. 6b) . The crystal structure of A. thaliana cyclic nucleotide phosphoesterase (CNP) in complex with cyclic 2′-3′ uridine vanadate 38 ( Fig. 5d) reveals that, in a manner similar to that of the AKAP18-AMP complex (Fig. 5a) , the His-x-Thr motifs are responsible for coordinating the oxyanion moiety of the nucleotide, although in this instance the phosphate is replaced by vanadate and is cyclised between the 2′-3′ ribose positions. The base and ribose moieties of cyclic 2′-3′ uridine vanadate are coordinated differently, in comparison to 5′AMP in complex with AKAP18, which enables the cyclic vanadate to be accommodated (Supplementary Fig. S2 ). In both complexes, phenylalanine residues, although located differently (Phe84 in the A. thaliana CNP, Fig. 5d ; Phe179 in AKAP18, Fig. 5a ), are important for coordinating the base moiety.
In an attempt to test the possibility that AKAP18δ can function as a 2′-5′ RNA ligase, crystallisation of AKAP18 CD was performed in the presence of two nucleotides which, according to the reaction mechanism illustrated in Fig. 6a , would be expected to bind to AKAP18
CD when present at high concentration. Co-crystallisations were performed with 5 mM 3′AMP to mimic the tRNA 3′ half-molecule (Fig.  6d) , and with 5 mM 2′-3′ cCMP to mimic the tRNA 5′ half-molecule (Fig. 6e) . Neither nucleotide bound to AKAP18 CD (Fig. 2a) . These results are inconsistent with the notion that AKAP18δ functions as a 2′-5′ RNA ligase. Furthermore, there is no existing evidence that AKAP18δ binds RNA or is involved in any form of RNA processing.
Given the ability of AKAP18δ to bind 5′AMP, a product of 3′-5′ cAMP hydrolysis, the capacity of 36 (c) T. thermophilus 2′-5′ RNA ligase (PDB ID 1IUH). 37 (d) A. thaliana 1′-2′-cyclic nucleotide 2′-phosphodiesterase in complex with cyclic 2′-3′ uridine vanadate (PDB ID 1JH7).
38
2H phosphoesterases to hydrolyse phosphodiesters with different ribose linkages, and the role of AKAP18 in anchoring PKA that responds to 3′-5′ cAMP, we tested the hypothesis that the AKAP18δ central domain might function as a 3′-5′ cAMP phosphodiesterase. However, AKAP18δ displayed no cAMP or cGMP phosphodiesterase activity regardless of the cyclic nucleotide concentration or pH tested (Fig. 6f) , a finding consistent with the lack of binding of 3′-5′ cAMP in the crystal (Fig. 2a) . Binding of 3′AMP and cyclic 2′-3′ CMP to AKAP18δ was attempted to test the potential of AKAP18δ to act as a 2′-5′ RNA ligase, the rational being that these molecules would mimic 3′ (d) and 5′ (e) tRNA half-molecules, respectively. (f) AKAP18δ was assayed for cAMP phosphodiesterase activity. Assays were performed using immunoprecipitated V5 epitope-tagged full-length AKAP18δ (light grey bars), with different concentrations of cAMP (lanes 1 and 2) and at different pH (lanes 1, 3 and 4) , in each instance including negative (untransfected, white bars) and positive (PDE4D3, dark grey bars) controls. AKAP18δ activity did not differ significantly from the negative control in any condition.
Discussion
In this study we have, to our knowledge, performed the first systematic bioinformatic analysis to define domain structures within the AKAP superfamily. Using protein fold recognition approaches, we identified domains within AKAPs that had not been recognised previously. Some novel domain definitions are supported by a high degree of sequence similarity to structural homologues, whereas for others, the degree of sequence similarity is not statistically significant. We defined one such domain of AKAP18γ/δ as belonging to the 2H phosphoesterase family. Crystallographic analysis of AKAP18 CD confirmed this prediction, providing the first structural information concerning a functional domain within an AKAP. Nucleotide binding experiments indicate that AKAP18 CD specifically interacts with 5′AMP and 5′CMP.
Our studies indicate two possible biological functions for the central domain of AKAP18δ. Its resemblance to tRNA ligases and CNPs of the 2H phosphoesterase family suggests that it either hydrolyses or ligates cyclic nucleotide phosphodiesters; however, we could not detect catalytic activity associated with the protein. The other possibility is that AKAP18δ acts as a 5′AMP effector. 5′AMP functions as an energy sensor to mediate cell signalling, with increased AMP concentrations triggering the activation of both AMP kinase 44 and glycogen phosphorylase.
45 5′AMP stimulates AMP kinase with an EC 50 in the low micromolar range, 46 whereas glycogen phosphorylase is converted to the activated conformation with an EC 50 of ∼ 75 μM in the absence of glucose 6-phosphate. 47 In contrast, the affinity of AKAP18 CD for AMP is slightly lower. Its affinity for 5′AMP is likely to be similar to that of MANT-AMP (K d of 194 μM), as the 2′ and 3′ ribose hydroxyl groups, modified in MANT-AMP, are accessible, unhindered by protein contacts (Fig. 3b) .
If we assume that the central domain of AKAP18δ acts as a 5′AMP sensor, how might 5′AMP propagate an effect on binding to the protein? Structural rearrangements on engaging 5′AMP are restricted to ordering of the R loop and a small shift in position of the loop harbouring Lys229 (Fig. 7a) . Binding of 5′AMP also alters the shape and charge of the protein surface. Both hydroxyl groups of the 5′AMP ribose moiety are available for interaction, and nucleotide binding neutralises a region of positive charge at the base of the binding groove. A region comprising highly conserved residues (CR2), including residues Asp266-Gln275, lies adjacent to the binding groove (Figs. 1a and 7b ) and could potentially be involved in AKAP18δ-mediated intermolecular interactions.
5′AMP binding might affect AKAP18δ activity in multiple ways. The conformational change and altered surface properties accompanying AMP binding could modulate the protein's cellular localisation. One possibility is an influence on the nuclear localisation of the protein, reminiscent of ligandmediated nuclear targeting of steroid hormone receptors. 48 AKAP18γ/δ comprises a conserved nuclear localisation sequence (NLS) 49 immediately N-terminal to the central domain (Fig. 1b) . 25 Mutation of the NLS prevents nuclear localisation of AKAP18γ expressed in HEK293 cells. 25 The NLS sequence, although present in AKAP18 CD , was not visible in the electron density. The most N-terminal residue with discernible electron density is Tyr88 whose C α atom is positioned 12 Å from the ribose 2′-hydroxyl group in the AKAP18δ-5′AMP complex structure (Fig. 7a) , consistent with the possibility that the NLS could interact with elements involved in forming the AKAP18δ-5′AMP complex. There are other targeting mechanisms that could be subject to 5′AMP regulation: AKAP18δ is present on aquaporin 2-bearing vesicles in the kidney, 29 although the basis of this targeting is unknown. Alternatively, 5′AMP could affect the interaction of AKAP18δ with an associated protein. Recently, the AKAP18δ central domain was shown to interact with PDE4D3/9; 31 however, we could not detect an influence of 1 mM AMP on AKAP18δ interactions with either PDE4D6 or the PKA regulatory RII subunits (data not shown).
The phosphoesterase domain presented here is the first structure of a domain within an AKAP and is the first demonstration of an AKAP with the ability to bind a small molecule. The 5′AMP complex structure provides insight into the mechanism of 2′-5′ RNA ligases and should prove useful in understanding other members of the 2H phosphoesterase superfamily. These studies generate two functional hypotheses for AKAP18δ. First, the protein may act enzymatically as a phosphoesterase, although we did not identify a substrate. Alternatively, AKAP18δ may play a role as an AMP sensor, thereby coupling a metabolite effector protein with the primary intracellular receptor for cAMP (PKA). Our findings demonstrate the use of a combined bioinformaticstructural approach for uncovering new properties in proteins, and reveal another layer to the sophistication of AKAPs.
Materials and Methods
Protein expression and purification
Three constructs of rat AKAP18δ (IMAGE ID 7315112) spanning the full-length protein (1-353), central domain (76-292, AKAP18 CD ) and an N-terminal truncate (76-353) were cloned into pGEX6P1 and expressed as PreScission™-cleavable GST-fusion protein (GE Healthcare) from Escherichia coli BL21 Codon Plus® (DE3) cells (Stratagene). Cells were induced at OD 600nm = 0.5 with 0.5 mM IPTG and harvested after 16 h at 18°C. Cells were lysed by sonication and following centrifugation the supernatant fraction was applied to 5 ml Glutathione Sepharose™ beads (GE Healthcare). Bound recombinant protein was cleaved from the beads overnight with PreScission™ protease (GE Healthcare), and applied to a Superdex 75 gel filtration column (GE Healthcare) in 15 mM Tris-HCl (pH 7.5), 150 mM NaCl, 0.1 mM ethylenediaminetetraacetic acid (EDTA) and 2 mM DTT. The central domain eluted as a single peak on gel filtration. Selenomethioninesubstituted AKAP18 CD was produced in B834 (DE3) and purified as the native protein. Mouse PDE4D6 (90-518) (IMAGE ID 23274169) was produced by the same protocol. His-tagged AKAP18δ (76-353) was expressed in Sf 9 insect cells using the Bac-to-Bac Baculovirus Expression System (Invitrogen).
Crystallography
The best diffracting crystals grew in 0.1 M Tris-HCl, pH 8, 10% polyethylene glycol (PEG) 8000, 7 mM DTT by hanging-drop vapour diffusion at 14°C. Crystals were harvested after 1 week. For cryoprotection, crystals were immersed for 2 min in 0.1 M Tris-HCl, pH 8, 10% PEG 8000, 7 mM DTT, 75 mM NaCl and 25% glycerol, and then flash frozen at 100 K. Native and selenomethioninesubstituted data were collected at European Synchrotron Radiation Facility. Crystallographic programs were accessed via the CCP4 suite; 50 data were processed using MOSFLM and scaled and merged in SCALA (see Table 2 for details). Phases and initial electron density maps were calculated by SIRAS, using SHELX, and automatic model building was performed using ArpWarp before final rounds of manual model building and refinement using COOT 51 and REFMAC. Nucleotide co-crystallisation experiments were performed by including the specified concentration of nucleotide in both the precipitant solution and cryobuffer. Crystals were harvested after 1 week, and structures were solved by PHASER molecular replacement with, and REFMAC refinement against, the apo structure. The presence of bound nucleotide was determined by inspection of the difference F o − F c electron density map in COOT. Complexes with 5′AMP and 5′ CMP were further refined with REFMAC. Nucleotide and side chains for residues 219-220, invisible in the apo structure, were visible in the difference F o − F c electron density maps, so modelled in COOT before final refinement using REFMAC. Molecular representations in figures were created using the PyMOL Molecular Graphics System ‡ and BioDraw 10.0 (Merck). 
Pull-down assays
Pull-down assays were performed using GST-fusion proteins immobilised to glutathione Sepharose fast flow beads (GE Healthcare), and with 5′AMP-agarose (Sigma). For GST fusion pull-downs, GST-fusion protein was immobilised to the beads and washed with (500 mM NaCl, 25 mM Tris-HCl, pH 7.5, 2 mM DTT, 0.5 mM EDTA). Protein samples were then mixed with the beads in low salt buffer (150 mM NaCl, 25 mM Tris-HCl, pH 7.5, 2 mM DTT, 0.5 mM EDTA, 0.05% Tween 20). After washing away nonspecifically bound protein in low salt buffer, bound protein was detected by Western blotting, or cAMP phosphodiesterase assay in the case of PDE4D6. Pull-down with immobilised GST alone was routinely included as a negative control for pull-downs using GST fusion proteins.
Protein Data Bank accession numbers
Atomic coordinates have been deposited in the PDB with accession codes 2VFY (APO), 2VFK (5′AMP complex) and 2VFL (5′CMP complex).
